Related Experiment Video
Updated: Aug 16, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
DIGITALISATION OF THE PHARMACEUTICAL INDUSTRY IN KAZAKHSTAN: HOW IS THE SECTOR ADAPTING TO NEW REALITIES?
G Ganesh1, C Shertaeva2, G Umurzakhova2
11JSS College of Pharmacy, Ooty, India.
Georgian Medical News
|August 14, 2026
Summary
Digital transformation is crucial for the pharmaceutical industry
Area of Science:
- Pharmaceutical industry
- Digital transformation
- Health informatics
Background:
- Digitalization is reshaping the pharmaceutical sector globally.
- Kazakhstan's pharmaceutical market is undergoing significant digital changes.
- Adapting to new technologies is vital for competitiveness.
Purpose of the Study:
- Examine digital transformation in the pharmaceutical industry, focusing on Kazakhstan.
- Identify opportunities, barriers, and adaptation strategies for companies.
- Analyze the impact of technologies like AI and Big Data.
Main Methods:
- A narrative analytical review of secondary data.
- Analysis of scientific publications, regulatory documents, market reports, and industry media.
- Thematic analysis of sources using keywords related to pharmaceutical digitalization.
Main Results:
- Key areas include AI, Big Data, e-commerce, digital communication, and logistics.
- Kazakhstan shows progress in online pharmacies, medicine labeling, and logistics digitalization.
- While basic automation is widespread (97.2%), comprehensive systems are less common (23.7%).
Conclusions:
- Digitalization enhances pharmaceutical industry competitiveness.
- Successful transformation requires technology, data analysis, and patient focus.
- Future growth necessitates investment in AI, Big Data, infrastructure, and training.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:28Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...